Ebola Stocks Continue Higher
With over 700 already dead, the worst Ebola outbreak in history is pressuring the demand for development of new drugs to fight the Ebola virus.
On Friday, The U.S. Food and Drug Administration said the agency stands ready to work with companies to develop drugs for patients "in dire need of treatment."
Shares of all three companies were trading higher on the open, with TKMR up nearly 15 percent at $16.50.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.